Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|December 19, 2014
Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modificationsRemi Adelaiye, Eric Ciamporcero, Kiersten Marie Miles, et al.
Bioorganic & Medicinal Chemistry Letters|March 13, 2010
Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitorsMichael S Malamas, Keith Barnes, Yu Hui, et al.
Nature Biotechnology|November 9, 2007
The OBO Foundry: coordinated evolution of ontologies to support biomedical data integrationBarry Smith, Michael Ashburner, Cornelius Rosse, et al.
Plos One|March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtinWolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pocketsDerek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascadeJ Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Pageof 8